Danon Disease (DD) is a rare inherited X-linked lysosomal storage disease (LSD). This disease is caused by a mutation in the lysosomal-associated membrane protein type 2 gene (LAMP2, Xq24). Mutation of this gene cause skeletal and cardiac muscle problems, dysfunction of multisystem organs, and intellectual disability. As a consequence of X- chromosome inactivation, males experience dilated cardiomyopathy with atrial fibrillation. Females with one x chromosome mutation have milder clinical problems than males. Females with two mutated x chromosomes show similar clinical manifestations as males. The affected populations and prevalence of DD are unknown. Through LAMP2 genetic testing, our knowledge has increased; however, there are still no treatment options available to treat DD. This chapter summarizes the disease' classification, clinical manifestations, epidemiology, pathophysiology, diagnosis, supportive care, and future treatment.
CITATION STYLE
Bennett, L. L. (2023). Danon disease. In Frontiers in Lysosomal Storage Diseases (LSD) Treatments (pp. 269–276). Nova Science Publishers, Inc. https://doi.org/10.1161/circheartfailure.114.001105
Mendeley helps you to discover research relevant for your work.